Clinical Trial Update: Chemoprophylactic Activity of M5717 in PfSPZ Challenge Model [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the chemoprophylactic activity of M5717 against malaria using the PfSPZ Challenge model in healthy volunteers; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• M5717 (M5717)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2024-05-01